|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0007137,
umls-concept:C0020402,
umls-concept:C0205127,
umls-concept:C0205219,
umls-concept:C0332281,
umls-concept:C0439064,
umls-concept:C0521115,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2745955
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-8-11
|
|
pubmed:abstractText |
Hydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long-term treatment is associated with mucocutaneous adverse events and nail hyperpigmentation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1324-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18691992-Aged, 80 and over,
pubmed-meshheading:18691992-Aminoquinolines,
pubmed-meshheading:18691992-Antineoplastic Agents,
pubmed-meshheading:18691992-Carcinoma, Squamous Cell,
pubmed-meshheading:18691992-Humans,
pubmed-meshheading:18691992-Hydroxyurea,
pubmed-meshheading:18691992-Hyperpigmentation,
pubmed-meshheading:18691992-Male,
pubmed-meshheading:18691992-Myeloproliferative Disorders,
pubmed-meshheading:18691992-Nail Diseases,
pubmed-meshheading:18691992-Skin Neoplasms
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
|
|
pubmed:affiliation |
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy. rositasaraceno@yahoo.it
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
